CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08870Brentuximab vedotin2Active Not Recruiting1